Back to search results
NCT05809713

Heart to Heart: BP Control Partners

Enrolling by Invitation
NAAges 19+InterventionalHealth services
East Carolina University
~780 participants
Updated 2023-09-13 on ClinicalTrials.gov
What's tested:Technology-enabled Team CareEnhanced Usual Care

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Systolic Blood Pressure (SBP) level at 6 months follow-up
Measured over 6-months

Conditions

Hypertension

Explore related trials

Hypertension

Where it's being run

2 sites across 1 states
North Carolina2

Study leadership

  • Doyle Cummings, Pharm.D. · PRINCIPAL_INVESTIGATOR · East Carolina University Brody School of Medicine

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Hispanic and non-Hispanic black (≥50%) and white (≤50%) adults (\>18yr. old; 40% male)
diagnosis of essential hypertension,
a documented history of uncontrolled hypertension (mean SBP ≥ 140 mmHg from primary care office visits over the last year) and
elevated SBP (≥ 140 mmHg) (average of 2 research-grade measurements) at the time of enrollment.

Exclusion

severe chronic kidney disease (eGFR \< 30 ml/min/1.73m2),
substance abuse,
difficulty with communication in English without an interpreter,
dementia, mental illness or any condition that would limit ability to give informed consent
rare patients living in very remote areas where cellular- enabled telemonitoring is not feasible will be excluded.
Pregnancy; female participants will be asked to report pregnancy status during pre-screening and at study baseline. Participants who report pregnancy prior to randomization will be excluded from the study. If the participant becomes pregnant during the study, prescribed medication(s) will be rapidly tapered or immediately discontinued, as indicated and the patient referred back to their primary care provider for follow-up.

What this trial measures

  • Change in Systolic Blood Pressure (SBP) level at 6 months follow-up6-months

    Change from baseline visit to six-months follow-up visit in measured SBP